MGP INGREDIENTS INC
For the period ended Sep 30, 2026. Filed Oct 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 28, 2026
MGPI$17.12-0.5%Stored close · as of Oct 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year to Date Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash Flows from Operating Activities | ||
| Net income (loss) | $(115,910) | $26,799 |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 19,069 | 17,824 |
| Goodwill and other long-lived assets impairment | 179,526 | — |
| Share-based compensation | 4,002 | 3,320 |
| Equity method investment gain | (290) | (869) |
| Deferred income taxes, including change in valuation allowance | (42,729) | (25) |
| Change in fair value of contingent consideration | — | 25,500 |
| Payment of contingent consideration | (48,700) | — |
| Other, net | 803 | 594 |
| Changes in operating assets and liabilities: | ||
| Receivables, net | 21,494 | 41,699 |
| Inventory | (18,191) | (19,935) |
| Prepaid expenses | (1,419) | (163) |
| Income taxes payable | 7,424 | 1,442 |
| Accounts payable | (8,172) | (8,446) |
| Accrued expenses and other | (2,521) | 7,689 |
| Federal and state excise taxes payable | (3,856) | (2,906) |
| Other, net | 610 | (74) |
| Net cash provided by (used in) operating activities | (8,860) | 92,449 |
| Cash Flows from Investing Activities | ||
| Additions to property, plant, and equipment | (14,878) | (40,674) |
| Distributions from equity method investment | 1,500 | — |
| Other, net | 168 | (14) |
| Net cash used in investing activities | (13,210) | (40,688) |
| Cash Flows from Financing Activities | ||
| Payment of dividends and dividend equivalents | (7,797) | (7,739) |
| Repurchase of Common Stock | (921) | (1,035) |
| Loan fees paid related to borrowings | — | (2,712) |
| Proceeds from long-term debt | 145,000 | 28,000 |
| Principal payments on long-term debt | (56,800) | (80,800) |
| Payment of contingent consideration | (62,100) | — |
| Net cash provided by (used in) financing activities | 17,382 | (64,286) |
| Effect of exchange rate changes on cash and cash equivalents | (171) | 699 |
| Decrease in cash and cash equivalents | (4,859) | (11,826) |
| Cash and cash equivalents, beginning of period | 18,460 | 25,273 |
| Cash and cash equivalents, end of period | $13,601 | $13,447 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.